Fred Alger Management’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3M | Sell |
173,013
-1,735
| -1% | -$32.8K | 0.01% | 279 |
|
|
2025
Q4 | $3.29M | Sell |
174,748
-754,275
| -81% | -$12.6M | 0.01% | 281 |
|
|
2025
Q3 | $13.5M | Sell |
929,023
-304,736
| -25% | -$4.34M | 0.05% | 160 |
|
|
2025
Q2 | $24.1M | Sell |
1,233,759
-200,848
| -14% | -$3.57M | 0.11% | 104 |
|
|
2025
Q1 | $25.5M | Sell |
1,434,607
-179,385
| -11% | -$3.86M | 0.15% | 98 |
|
|
2024
Q4 | $34.6M | Buy |
1,613,992
+110,471
| +7% | +$2.69M | 0.16% | 93 |
|
|
2024
Q3 | $46.9M | Buy |
1,503,521
+353,919
| +31% | +$8.81M | 0.23% | 79 |
|
|
2024
Q2 | $17.9M | Buy |
1,149,602
+963,554
| +518% | +$11.6M | 0.09% | 138 |
|
|
2024
Q1 | $1.97M | Buy |
+186,048
| New | +$1.86M | 0.01% | 346 |
|
|
2023
Q2 | – | Sell |
-35
| Closed | -$320 | – | 522 |
|
|
2023
Q1 | $320 | Sell |
35
-503,651
| -100% | -$6.44M | ﹤0.01% | 511 |
|
|
2022
Q4 | $5.75M | Sell |
503,686
-1,477,478
| -75% | -$21.9M | 0.03% | 249 |
|
|
2022
Q3 | $33.7M | Sell |
1,981,164
-908,065
| -31% | -$19.5M | 0.17% | 140 |
|
|
2022
Q2 | $62.1M | Sell |
2,889,229
-605,253
| -17% | -$16.8M | 0.29% | 97 |
|
|
2022
Q1 | $129M | Buy |
3,494,482
+223,509
| +7% | +$8.71M | 0.41% | 76 |
|
|
2021
Q4 | $149M | Sell |
3,270,973
-166,844
| -5% | -$8.71M | 0.37% | 85 |
|
|
2021
Q3 | $218M | Buy |
3,437,817
+11,844
| +0.3% | +$902K | 0.52% | 68 |
|
|
2021
Q2 | $314M | Sell |
3,425,973
-680,337
| -17% | -$54.1M | 0.74% | 32 |
|
|
2021
Q1 | $280M | Sell |
4,106,310
-1,247,643
| -23% | -$96.9M | 0.73% | 31 |
|
|
2020
Q4 | $388M | Buy |
5,353,953
+252,861
| +5% | +$14.7M | 1.01% | 15 |
|
|
2020
Q3 | $194M | Buy |
5,101,092
+15,155
| +0.3% | +$512K | 0.56% | 46 |
|
|
2020
Q2 | $180M | Sell |
5,085,937
-39,393
| -0.8% | -$1.12M | 0.59% | 40 |
|
|
2020
Q1 | $112M | Sell |
5,125,330
-59,603
| -1% | -$1.34M | 0.49% | 50 |
|
|
2019
Q4 | $112M | Buy |
5,184,933
+514,008
| +11% | +$11.8M | 0.41% | 67 |
|
|
2019
Q3 | $106M | Buy |
4,670,925
+1,523,267
| +48% | +$42.2M | 0.41% | 61 |
|
|
2019
Q2 | $113M | Sell |
3,147,658
-1,222,361
| -28% | -$39.1M | 0.44% | 60 |
|
|
2019
Q1 | $138M | Buy |
4,370,019
+166,329
| +4% | +$4.85M | 0.55% | 46 |
|
|
2018
Q4 | $106M | Buy |
4,203,690
+763,070
| +22% | +$19.6M | 0.49% | 49 |
|
|
2018
Q3 | $99.3M | Buy |
3,440,620
+177,830
| +5% | +$3.33M | 0.37% | 59 |
|
|
2018
Q2 | $39.9M | Buy |
3,262,790
+1,241,668
| +61% | +$14.2M | 0.17% | 102 |
|
|
2018
Q1 | $16.1M | Buy |
2,021,122
+782,771
| +63% | +$4.82M | 0.07% | 158 |
|
|
2017
Q4 | $9.09M | Buy |
+1,238,351
| New | +$7.72M | 0.04% | 187 |
|
Other funds holding CDNA
AIM
DM
B
VCM
GS
Fred Alger Management's CDNA Position: Q1 2026 in Review
Fred Alger Management reduced its CareDx (CDNA) stake by 0.99% in Q1 2026, selling an estimated $32.8K and leaving 173,013 shares worth $3M. The position accounts for 0.01% of the portfolio, ranked #279.
Fred Alger Management first reported a position in CDNA in Q4 2017 and has held it in 31 quarters since. The position peaked at $388M in Q4 2020. 190 funds tracked by Wall St. Rank hold CDNA as of Q1 2026.
- Fred Alger Management held 173,013 shares of CareDx worth $3M as of Q1 2026.
- Fred Alger Management sold 1,735 CareDx shares in Q1 2026, an estimated $32.8K.
- CareDx made up 0.01% of Fred Alger Management's portfolio in Q1 2026, its #279 holding.
- Fred Alger Management first reported a position in CareDx in Q4 2017 and has held it in 31 quarters since.
- Fred Alger Management's CareDx position peaked at $388M in Q4 2020.
- 190 funds tracked by Wall St. Rank held CareDx as of Q1 2026.
Based on Fred Alger Management's 13F filing for Q1 2026, filed 15 May 2026.